ArticleEBioMedicine2026

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

Puran Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.